Drug & Medication Database

Brain Supp Supports brain health.

Brands: Brain Supp

PURPOSE Neurotrophic Support

Brands: Guna-bdnf

Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: BRASSICA RAPA POLLEN (.05 g/mL). Category: BLA.

Brands: Mustard Pollen

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BROCCOLI (.025 g/mL). Category: BLA.

Brands: Broccoli

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: CABBAGE (.05 g/mL). Category: BLA.

Brands: Cabbage

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BRASSICA RAPA POLLEN (.05 g/mL). Category: BLA.

Brands: Mustard

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BRAZIL NUT (.1 g/mL). Category: BLA.

Brands: Food - Plant Source, Brazil Nut Bertholletia Excelsa

Purpose #1 First-aid Remedy for the relief of Bruises, Injuries, Muscle Aches, Pre/Post Surgery, Pain Relief Homeopathic Medicine PARABENS FREE

Brands: Brazmedics Arnica Cream

Promoting Blood Circulation in The Breast Alleviating Breast Nodules

Brands: Breast Nodule

Purpose Sunscreen

Brands: Breath Fresh Spf 15 Broad Spectrum Lip Balm

Brands: Air

11 DESCRIPTION VYLEESI (bremelanotide injection) contains bremelanotide, a melanocortin receptor agonist for subcutaneous administration via an autoinjector. Bremelanotide acetate is a synthetic, cyclic heptapeptide with a free acid at the carboxyl terminus and an acetylated amino group at the amino terminus of the peptide with the following structure: Ac-Nle-cyclo-(Asp-His-D-Phe-Arg-Trp-Lys-OH) ● xCH 3 COOH The molecular formula of bremelanotide acetate is C 50 H 68 N 14 O 10 ● xCH 3 COOH (1≤ x

Brands: Vyleesi

Dosage form: POWDER. Active ingredients: PEPTIDE B27PD (1 g/g). Category: BULK INGREDIENT.

11 DESCRIPTION BRINSUPRI (brensocatib) is a dipeptidyl peptidase 1 (DPP1) inhibitor. The chemical name for the active ingredient brensocatib monohydrate is (2 S )- N -{(1 S )-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide monohydrate with a chemical formula of C 23 H 24 N 4 O 4 ∙ H 2 O which corresponds to a molecular weight of 438.48 g/mol.

Brands: Brinsupri

11 DESCRIPTION ADCETRIS (brentuximab vedotin) is a CD30-directed antibody and microtubule inhibitor conjugate consisting of three components: 1) the chimeric IgG1 antibody cAC10, specific for human CD30, 2) the microtubule disrupting agent MMAE, and 3) a protease-cleavable linker that covalently attaches MMAE to cAC10. Brentuximab vedotin has an approximate molecular weight of 153 kDa. Approximately 4 molecules of MMAE are attached to each antibody molecule.

Brands: Adcetris

Dosage form: POWDER. Active ingredients: BRETYLIUM TOSYLATE (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Dosage form: POWDER. Active ingredients: BREXANOLONE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION Brexpiprazole, an atypical antipsychotic, is available as REXULTI ® (brexpiprazole) tablets. Brexpiprazole is 7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1 H )-one. The empirical formula is C 25 H 27 N 3 O 2 S, and its molecular weight is 433.57. The chemical structure is: REXULTI tablets are for oral administration and are available in 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg strengths.

Brands: Rexulti

11 DESCRIPTION TECARTUS (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. To prepare TECARTUS, a patient's own T cells are harvested and genetically modified ex vivo by retroviral transduction to express a chimeric antigen receptor (CAR) comprising a murine anti-CD19 single-chain variable fragment (scFv) linked to CD28 and CD3-zeta co-stimulatory domains.

Brands: Tecartus

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Bridged Chlorinated Ring Combination 9313

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Bridged Phenyl Combination 9312

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Bridged Ring Combination 9311

11 DESCRIPTION Brigatinib is a kinase inhibitor. The chemical name for brigatinib is 5-chloro-N 4 -[2-(dimethylphosphoryl)phenyl]-N 2 -{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine. The molecular formula is C 29 H 39 ClN 7 O 2 P which corresponds to a formula weight of 584.10 g/mol. Brigatinib has no chiral centers. The chemical structure is shown below: Brigatinib is an off-white to beige/tan solid.

Brands: Alunbrig

TissueBlue 0.025% - Description section TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is a sterile solution of BBG (a dye) for intraocular ophthalmic use. Each mL of TissueBlue 0.025% contains BBG 0.25 mg, polyethylene glycol and buffered sodium chloride solution (sodium chloride, dibasic sodium phosphate, monobasic sodium phospage, water for injection). Phosphoric acid and/or sodium hydroxide may also be used for pH adjustment.

Brands: Tissueblue

11 DESCRIPTION Brimonidine Topical Gel, 0.33% contains brimonidine tartrate, an alpha adrenergic agonist. The molecular formula of brimonidine tartrate is C 11 H 10 BrN 5 • C 4 H 6 O 6 . It has the following structural formula: Chemically, brimonidine tartrate is 5-Bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate. Brimonidine tartrate has a molecular weight of 442.24 and appears as white to slightly yellowish powder.

Brands: Brimonidine

Dosage form: POWDER. Active ingredients: BRIMONIDINE TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

Brimonidine tartrate is a redness reliever eye drop for relief of redness of the eye due to minor eye irritations.

Brands: Lumify Preservative Free Eye Drops

Brimonidine tartrate and timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension.

Brands: Brimonidine Tartrate/timolol Maleate Ophthalmic Solution

11 DESCRIPTION Brimonidine tartrate ophthalmic solution 0.15%, sterile, is a relatively selective alpha-2 adrenergic receptor agonist (topical intraocular pressure lowering agent). The structural formula of brimonidine tartrate is: 5-bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate; MW= 442.24 In solution, brimonidine tartrate ophthalmic solution has a clear, greenish-yellow color. It has an osmolality of 250-350 mOsmol/kg and a pH of 6.6-7.4.

Brands: Brimonidine Tartrate Ophthalmic Solution, 0.15%

11 D ESCRIPTION COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, sterile, is a relatively selective alpha-2 adrenergic receptor agonist with a non-selective beta-adrenergic receptor inhibitor (topical intraocular pressure lowering agent).

Brands: Combigan